Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/9887 stock hub

HKG/9887 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/9887is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
16B
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/9887
In the news

Latest news · HKG/9887

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.7P50 18.9P75 41.4
Trailing P/En/a
P25 10.7P50 17.9P75 38.5
ROE-27.6
P25 -14.7P50 2P75 9.4
ROIC-11.7
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/9887 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
149
Groups with data
10
Currency
CNY
Showing 149 of 149 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
China
Country code
HK
Employees
244
Enterprise value
HKD 14.6B
Exchange
Hong Kong Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
CNE1000070H8
Last refreshed
2026-05-10
Market cap
HKD 16B
Price
HKD 80.6
Price currency
HKD
Rev Per Employee
808,406.48x
Sector
Healthcare
Sic
2836
Symbol
hkg/9887
Website
https://www.leadsbiolabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-1.47%
EV Earnings
-62.14x
EV/FCF
-80.77x
EV/Sales
74.12x
FCF yield
-1.13%
P/B ratio
11.38x
P/S ratio
81.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

12
MetricValue
EBIT Margin
-109.75%
EBITDA Margin
-100.93%
Gross margin
100%
Gross Profit
HKD 197.3M
Net Income
HKD -235.3M
Pretax Margin
-110.51%
Profit Margin
-119.27%
Profit Per Employee
HKD -964,218
ROA
-9.92
ROCE
-15.21
ROE
-27.61
ROIC
-11.7

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
HKD 0.14
Assets
HKD 2B
Cash
HKD 1.7B
Current Assets
HKD 1.9B
Current Liabilities
HKD 578.3M
Debt
HKD 312.2M
Debt Equity
HKD 0.22
Debt FCF
HKD -1.72
Equity
HKD 1.4B
Interest Coverage
-27.06
Liabilities
HKD 573.8M
Long Term Assets
HKD 36M
Long Term Liabilities
HKD -4.5M
Net Cash
HKD 1.4B
Net Cash By Market Cap
HKD 8.8
Net Cash Growth
365.57%
Net Debt Equity
HKD -1
Tangible Book Value
HKD 1.4B
Tangible Book Value Per Share
HKD 7.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
3.37
Net Working Capital
HKD -103.3M
Quick ratio
3.08
Working Capital
HKD 1.3B
Working Capital Turnover
HKD 0.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-16.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

29
MetricValue
50-day SMA
74
All Time High
97.5
All Time High Change
-17.33%
All Time High Date
2026-04-16
All Time Low
44.72
All Time Low Change
80.23%
All Time Low Date
2025-12-30
ATR
4.79
Beta1y
1.24
Ch YTD
58.04
High
81.7
High52
97.5
High52 Date
2026-04-16
High52ch
-17.33%
Low
78.2
Low52
44.72
Low52 Date
2025-12-30
Low52ch
80.23%
Ma50ch
8.92%
RSI
50.85
RSI Monthly
0
RSI Weekly
59.61
Sharpe ratio
0.63x
Sortino ratio
1.13
Total Return
-16.1%
Tr YTD
58.04
Tr1m
-9.39%
Tr1w
2.81%
Tr3m
28.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
HKD -216.5M
Operating margin
-109.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
134,504,379%
Net Borrowing
-725,484.7
Shares Insiders
7.18%
Shares Institutions
15.67%
Shares Out
198,891,800
Shares Qo Q
0%
Shares Yo Y
16.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
HKD -192M
Average Volume
761,726.8x
Bv Per Share
7.08
CAPEX
HKD -9.2M
Ch1m
-9.39
Ch1w
2.81
Ch3m
28.55
Ch6m
37.9
Change
1.77%
Change From Open
1.64
Close
79.2
Days Gap
0.13
Depreciation Amortization
18,004,688.3
Dollar Volume
53,636,720.8
Earnings Date
2026-05-29
EBIT
HKD -216.5M
EBITDA
HKD -199.1M
EPS
HKD -1.35
F Score
2
FCF
HKD -181M
FCF EV Yield
-1.24x
FCF Per Share
HKD -0.91
Financing CF
1,324,517,946
Fiscal Year End
December
Founded
2,012
Income Tax
HKD 17.3M
Investing CF
-183,758,356
Is Primary Listing
1
Last Earnings Date
2026-03-27
Last Report Date
2025-12-31
Ma150
63.65
Ma150ch
26.62%
Ma20
84.68
Ma20ch
-4.82%
Net CF
944,339,679
Next Earnings Date
2026-05-29
Open
79.3
Position In Range
68.57
Ppne
56,443,863
Price Date
2026-05-08
Ptbv Ratio
11.4
Relative Volume
0.86x
Revenue
197,251,181x
SBC By Revenue
5.56x
Share Based Comp
10,957,843
Tax By Revenue
8.76x
Tr6m
37.9%
Volume
665,468
Z Score
13.3
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HKG/9887 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/9887?

Insider, institutional, and short-interest positioning.

Institutional ownership
+15.7%
Share of float held by funds and institutions
Insider ownership
+7.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+16.1%
Negative means the company is buying back shares.
Technical

HKG/9887 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
50.9
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.63
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/9887

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/9887 stock rating?

hkg/9887 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/9887 analysis?

The full report lives at /stocks/hkg/9887/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/9887?

The latest report frames hkg/9887 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/9887 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.